공고 • Jul 15
Novanta Inc. to Report Q2, 2026 Results on Aug 05, 2026 Novanta Inc. announced that they will report Q2, 2026 results on Aug 05, 2026 공고 • Jun 11
Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion. Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion on June 8, 2026. A cash consideration of $1.2 billion will be paid by Novanta Inc. Novanta Inc. will pay a milestone payment of $250 million in the first quarter of 2027. Upon completion of the transaction, Riverpoint Medical will be reported under Novanta’s Medical Solutions operating segment. The transaction will be financed through a combination of cash on hand and Novanta’s existing credit facility, and the recently completed $300 million equity raise.
The transaction is subject to customary regulatory approvals and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the third quarter of 2026. The transaction is expected to be immediately accretive in 2026 to Novanta’s Adjusted Diluted Earnings Per Share, and in 2027 accretive to revenue growth rate, Adjusted Gross and EBITDA Margins, Adjusted Diluted Earnings Per Share, and Operating Cash Flows.
Robert W. Baird & Co. Incorporated acted as financial advisor for Novanta Inc. Jefferies LLC acted as financial advisor for Riverpoint Medical, LLC. J.P. Morgan Securities LLC acted as financial advisor for Novanta Inc. King & Spalding LLP acted as legal advisor for Novanta Inc. Matthew J. Byron, Melissa Rones, Emily Karlberg, Renata Ferrari, Pamela Glazier, Samer Musallam, Lisa Kaltenbrunner, Emerson Siegle, Deidre Johnson, Ryan Murphey, Rebecca Liu, Heather Sprague, Alison McLaughlin, and Kurt Fowler of Ropes & Gray LLP acted as legal advisor for Novanta Inc. Joshua Klatzkin, Matthew M. Mauney, and Michael Amalfe of Goodwin Procter LLP acted as legal advisor for Riverpoint Medical, LLC. 공고 • Jun 10
Novanta Inc. announced that it expects to receive $299.99998 million in funding Novanta Inc. entered into a Securities Purchase Agreement and announced a private placement of 2,142,857 Common Shares of the company at an issue price of $140 for gross proceeds up to $300.0 million on June 8, 2026. The transaction involves participation from institutional and other accredited investors. The private placement is expected to close on or about June 11, 2026, subject to satisfaction of customary closing conditions. 공고 • May 12
Novanta Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2026 Novanta Inc. provided earnings guidance for the second quarter and full year of 2026. For the quarter, the company expects GAAP revenue to be in the range of $259 million to $264 million.
For the year, the company expects GAAP revenue to be in the range of $1,040 million to $1,055 million. 공고 • Apr 14
Novanta Inc. to Report Q1, 2026 Results on May 11, 2026 Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026 공고 • Feb 24
Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026 Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million.
For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million. 공고 • Feb 10
Novanta Inc., Annual General Meeting, May 28, 2026 Novanta Inc., Annual General Meeting, May 28, 2026. 공고 • Jan 22
Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026 Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026 공고 • Nov 07
Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.
Security Name: Units
Security Type: Debt/Equity Composite Units
Securities Offered: 11,000,000
Price\Range: $50
Discount Per Security: $1.375